National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

arcitumomab
A murine IgG monoclonal Fab fragment antibody labeled with technetium-99m directed against carcinoembryonic antigen (CEA), a protein that is overexpressed by many tumor cell types. For tumors that overexpress CEA, arcitumomab may be used as an adjunct diagnostic imaging tool to obtain prognostic information following resection and to monitor for recurrent disease. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment
IMMU-4
US brand name:CEA-Scan



Previous:Aquadiol, Aquaphor, Aquasol A, Aranesp, Arava
Next:Arcoxia, Aredia, arginine butyrate, ArginMax, Aricept

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov